USD
GBP
CAD
AUD
Benzodiazepines
Gidazepam 3mg Pellets
| QUANTITY | PRIC PER pellet | SAVE AMOUNT |
|---|---|---|
| 10 to 19 | EUR 1.00 /pellet | 0% |
| 20 to 29 | EUR 0.90 /pellet | 10% |
| 30 to 49 | EUR 0.85 /pellet | 15% |
| 50 to 99 | EUR 0.75 /pellet | 25% |
| 100 to 249 | EUR 0.60 /pellet | 40% |
| 250 to 499 | EUR 0.50 /pellet | 50% |
| 500 + | EUR 0.35 /pellet | 65% |
POPULAR PRODUCT
Many customers bought this product recently.
Now
Packaging
price
Gidazepam 3mg Pellets
Gidazepam, also referred to as hydazepam or hidazepam, is an atypical benzodiazepine derivative that was developed in the Soviet Union. This compound is recognized for its selective anxiolytic properties and has demonstrated therapeutic value in the management of certain cardiovascular disorders.
Pharmacology
Unlike many other benzodiazepines, gidazepam and its analogs are comparatively more selective agonists of the translocator protein (TSPO), previously known as the peripheral benzodiazepine receptor, rather than the traditional benzodiazepine receptor. Gidazepam functions as a prodrug, converting into its active metabolite, 7-bromo-2,3-dihydro-5-phenyl-1H-1,4-benzodiazepin-2-one (also known as desalkylgidazepam or bromo-nordazepam). The anxiolytic effects of gidazepam may take several hours to become apparent, likely due to its slow metabolism, with a half-life of approximately 87 hours. The onset and intensity of its anxiolytic effects are correlated with the blood levels of desalkylgidazepam, the active metabolite responsible for its therapeutic effects.
Clinical Data
Gidazepam is marketed under the trade name Gidazepam IC and is administered orally. Its legal status varies by region, classified as Schedule IV in Canada, unscheduled in the United States, and prescription-only in Ukraine.
Pharmacokinetic Data
The metabolism of gidazepam occurs hepatically, with renal excretion of its metabolites. The elimination half-life is approximately 87 hours, indicating a prolonged duration of action.
Chemical Information
The IUPAC name for gidazepam is 2-(9-Bromo-3-oxo-6-phenyl-2,5-diazabicyclo[5.4.0]undeca-5,8,10,12-tetraen-2-yl)acetohydrazide. Its chemical formula is C17H15BrN4O2, with a molar mass of 387.237 g·mol−1. The CAS number for gidazepam is 129186-29-4, and it is indexed in PubChem with the CID 121919.
Conclusion
Gidazepam represents a unique addition to the benzodiazepine class, distinguished by its selective anxiolytic effects and potential cardiovascular benefits. Its pharmacological profile, characterized by a long half-life and the formation of an active metabolite, positions it as a noteworthy compound for further clinical exploration.
Gidazepam 3mg Pellets is for research use only and not intended for human consumption!
Gidazepam 3mg Pellets stock last updated at: April 2025